DEFA14A: Elevance Health Corrects Executive Compensation Disclosure After Administrative Error

Elevance Health files a supplement to its proxy statement to correct an error in the Summary Compensation Table, which omitted a one-time cash award to the CFO, Mark B. Kaye.

Summary

• Elevance Health is issuing a supplement to its definitive proxy statement due to an administrative error.
• The original proxy statement, filed on March 29, 2024, omitted a $2,500,000 one-time cash award paid to Mark B. Kaye, the Executive Vice President and Chief Financial Officer, upon his commencement of employment.
• This award was intended to compensate Mr. Kaye for forfeited bonus payments and other incentives from his previous employer, as disclosed in a Form 8-K filed on August 8, 2023.
• Mr. Kaye is required to repay the bonus if he voluntarily resigns or is terminated for cause within three years of his start date.
• The supplement corrects the Summary Compensation Table and the Pay versus Performance section of the proxy statement to reflect the inclusion of the bonus.
• The Annual Meeting of Shareholders will be held on May 15, 2024, via live audio webcast.
• The corrected proxy materials are available on the company's website.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The document is a correction of an error, which is a negative, but the company is taking steps to rectify the situation, which is a positive. The overall impact is likely minimal.

Negatives

• An administrative error led to the omission of a significant compensation component in the initial proxy statement.

Risks

• The need to correct the proxy statement could raise concerns about the accuracy of financial disclosures.
• There is a clawback provision requiring Mr. Kaye to repay the bonus under certain termination scenarios.

Industry Context

The correction of executive compensation disclosures is a standard governance practice, ensuring transparency and accuracy for shareholders. Companies are expected to adhere to strict SEC guidelines in reporting executive pay.

Comparison to Industry Standards

• Executive compensation practices are often benchmarked against peer companies within the S&P 500 Health Care Index.
• The structure of compensation packages, including salary, bonus, stock awards, and other incentives, is typically aligned with industry standards to attract and retain top talent.
• Companies like UnitedHealth Group, CVS Health, and Cigna are often considered benchmarks for executive compensation in the healthcare sector.
• The use of performance-based metrics, such as adjusted net income and total shareholder return, is a common practice to align executive pay with company performance.

Stakeholder Impact

• Shareholders receive corrected information regarding executive compensation.
• The correction ensures transparency and may impact shareholder voting decisions.

Next Steps

• Shareholders are urged to vote their shares prior to the Annual Meeting using the methods described in the Proxy Statement.

Key Dates

Keywords

proxy statement, executive compensation, Mark B. Kaye, Elevance Health, CFO, bonus, disclosure, annual meeting